Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
April 1, 1993
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer
P W Johnson, S P Joel, S Love, et al.
British Journal of Cancer
|
April 1, 1993
Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas
P W Johnson, J Whelan, S Longhurst, et al.
Leukemia
|
April 1, 1994
The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9)
D M Lillington, S Monard, P W Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma
P W Johnson, C G Price, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
J Apostolidis, J M Foran, P W Johnson, et al.
British Journal of Cancer
|
August 1, 1996
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
L G Jørgensen, K Osterlind, J Genollá, et al.
Neuron
|
September 1, 1989
Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function
P W Johnson, W Abramow-Newerly, B Seilheimer, et al.
British Journal of Cancer
|
March 1, 1992
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years
A M Oza, T S Ganesan, M Dorreen, et al.
British Journal of Cancer
|
January 5, 2001
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer
P W Johnson, M F Muers, M D Peake, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Myelo-ablative therapy with peripheral blood progenitor cell (PBPC) support in patients with haematological malignancy
A Pigaditou, G Marini, P W Johnson, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
April 1, 1993
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer
P W Johnson, S P Joel, S Love, et al.
British Journal of Cancer
|
April 1, 1993
Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas
P W Johnson, J Whelan, S Longhurst, et al.
Leukemia
|
April 1, 1994
The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9)
D M Lillington, S Monard, P W Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma
P W Johnson, C G Price, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
J Apostolidis, J M Foran, P W Johnson, et al.
British Journal of Cancer
|
August 1, 1996
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
L G Jørgensen, K Osterlind, J Genollá, et al.
Neuron
|
September 1, 1989
Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function
P W Johnson, W Abramow-Newerly, B Seilheimer, et al.
British Journal of Cancer
|
March 1, 1992
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years
A M Oza, T S Ganesan, M Dorreen, et al.
British Journal of Cancer
|
January 5, 2001
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer
P W Johnson, M F Muers, M D Peake, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Myelo-ablative therapy with peripheral blood progenitor cell (PBPC) support in patients with haematological malignancy
A Pigaditou, G Marini, P W Johnson, et al.
Page
of 14